Serological scoring tools, such as Fib-4, APRI, and AST/ALT, have been integrated into clinical practice, but lack accuracy for the identification of early stages of, and minor changes in, liver fibrosis [25,26,27]. The gene discussed is GPT; the disease is Hepatic fibrosis.